Prolonged impact of COVID-19 pandemic on delayed melanoma diagnosis: further data based on one-year appraisal from Italy
https://doi.org/10.4081/dr.2022.9535
HTML: 8
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Not available.
Ricci F, Fania L, Paradisi A, et al. Delayed melanoma diagnosis in the COVID-19 era: increased breslow thickness in primary melanomas seen after the COVID-19 lockdown. J Eur Acad Dermatol Venereol 2020 Dec;34:e778-e779.
Marson JW, Maner BS, Harding TP et al. The magnitude of COVID-19’s effect on the timely management of melanoma and nonmelanoma skin cancers. J Am Acad Dermatol 2021;84:1100-3
Lallas A, Kyrgidis A, Manoli SM et al. Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: data from an institutional registry. J Am Acad Dermatol 2021.
Gisondi P, Cazzaniga S, Di Leo S, et al. Impact of the COVID-19 pandemic on melanoma diagnosis. J Eur Acad Dermatol Venereol 2021.
Lo Bello G, Pini GM, Ferguglia G, et al. Effects of COVID-19 restriction measures and clinical resetting on delayed melanoma diagnosis: a single Institution experience. Ital J Dermatol Venerol 2021.
Koch E, Villanueva F, Marchetti MA et al. Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study. J Eur Acad Dermatol Venereol 2021.
Copyright (c) 2022 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
